SCHEMBL14918554

SCHEMBL14918554

O=C(CCCCc1noc(C(F)(F)F)n1)Nc1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.53
HDAC8 Q9BY41 4/20 0.53
HDAC6 Q9UBN7 4/20 0.53
HDAC3 O15379 3/20 0.53
HDAC4 P56524 3/20 0.53
HDAC7 Q8WUI4 3/20 0.53
HDAC2 Q92769 3/20 0.53
HDAC10 Q969S8 3/20 0.53
HDAC11 Q96DB2 3/20 0.53
HDAC9 Q9UKV0 3/20 0.53
HDAC5 Q9UQL6 3/20 0.53
ALDH1A1 P00352 3/20 0.52
GAA P10253 2/20 0.52
POLB P06746 2/20 0.45
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14918855 0.99 HDAC1 (0.55) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL14918903 0.99 HDAC1 (0.55) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL14918844 0.99 HDAC1 (0.55) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL14918743 0.97 ALDH1A1 (0.56) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL14918438 0.92 GAA (0.49) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL14918419 0.86 HDAC4 (0.38) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL14918912 0.85 HDAC4 (0.38) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL14918624 0.85 HDAC4 (0.38) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL14918661 0.85 HDAC4 (0.38) HDAC1HDAC8HDAC6HDAC3HDAC4
SCHEMBL14919137 0.85 HDAC6 (0.43) HDAC1HDAC8HDAC6HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013066836-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2013-05-10 WO claimed
WO-2013066836-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2013-05-10 WO disclosed